Sustained Hair Regrowth With Ritlecitinib to Week 48 in Patients With Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b 3 Study. J of Skin 2023, 7 (2), s188. https://doi.org/10.25251/skin.7.supp.188.